Debby den Uyl - Concepedia

Author

Debby den Uyl

Amsterdam UMC Location Vrije Universiteit Amsterdam

Also Known As

D Den Uyl, D den Uyl, D. Den Uyl, D. den Uyl, Debby den Uyl

Publications

Citations

H-Index

Concepts

All Affiliations

Amsterdam UMC Location Vrije Universiteit Amsterdam Reade Westfriesgasthuis Amsterdam UMC Location University of Amsterdam University Medical Center Utrecht

About

Debby den Uyl is an author at Amsterdam UMC Location Vrije Universiteit Amsterdam specializing in medicine, rheumatology, and autoimmune disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	143
2	Rheumatology	2	2	76
3	Immunology	1	1	67
4	Neurology	1	1	44
5	Pathology	1	1	44

Debby den Uyl

Publications

667

Citations

H-Index

Page 1

	Year	Citations
Glucose tolerance, insulin sensitivity and β-cell function in patients with rheumatoid arthritis treated with or without low-to-medium dose glucocorticoids Jos N. Hoes, Marlies C. van der Goes, Daniël H. van Raalte, Annals of the Rheumatic Diseases	2011	112
Inactivating PSMB5 Mutations and P-Glycoprotein (Multidrug Resistance-Associated Protein/ATP-Binding Cassette B1) Mediate Resistance to Proteasome Inhibitors: Ex Vivo Efficacy of (Immuno)Proteasome Inhibitors in Mononuclear Blood Cells from Patients with Rheumatoid Arthritis Sue Ellen Verbrugge, Yehuda G. Assaraf, Ben A. C. Dijkmans, Journal of Pharmacology and Experimental Therapeutics	2012	107
A non-inferiority trial of an attenuated combination strategy (‘COBRA-light‘) compared to the original COBRA strategy: clinical results after 26 weeks Debby den Uyl, Marieke M. ter Wee, Maarten Boers, Annals of the Rheumatic Diseases	2013	100
Intensive combination treatment regimens, including prednisolone, are effective in treating patients with early rheumatoid arthritis regardless of additional etanercept: 1-year results of the COBRA-light open-label, randomised, non-inferiority trial Marieke M. ter Wee, Debby den Uyl, Maarten Boers, Annals of the Rheumatic Diseases	2014	71
Metabolic effects of high‐dose prednisolone treatment in early rheumatoid arthritis: Balance between diabetogenic effects and inflammation reduction Debby den Uyl, Daniël H. van Raalte, Michael T. Nurmohamed, Arthritis & Rheumatism	2011	68
Progression of HIV to AIDS: a protective role for HLA-B27? Debby den Uyl, Irene E. van der Horst‐Bruinsma, Michiel A. van Agtmael PubMed Hla ImmunogeneticsImmunologyImmunotherapyViral PersistenceHuman Retrovirus	2004	67
Subclinical synovitis detected by macrophage PET, but not MRI, is related to short-term flare of clinical disease activity in early RA patients: an exploratory study Yoony Y. J. Gent, Marieke M. ter Wee, Alexandre E. Voskuyl, Arthritis Research & Therapy Rheumatoid DisorderRheumatologyClinical Disease ActivityAutoimmune DiseaseRheumatic Diseases	2015	44
Glucocorticoid-induced osteoporosis Debby den Uyl, Irene E. M. Bultink, Willem F. Lems Skeletal TraumaRheumatologyBone DiseaseBone HealthGlucocorticoid-induced Osteoporosis	2004	32
Patient preference and acceptability of calcium plus vitamin D3 supplementation: a randomised, open, cross-over trial Debby den Uyl, Piet P. Geusens, F.N.R. van Berkum, Clinical Rheumatology	2009	22
Similar efficacy and safety of initial COBRA-light and COBRA therapy in rheumatoid arthritis: 4-year results from the COBRA-light trial N. Konijn, L. van Tuyl, Maarten Boers, Lara D. Veeken	2017	20

Page 1